Literature DB >> 14960891

The burden of genetic disorders in India and a framework for community control.

I C Verma1, S Bijarnia.   

Abstract

With a very large population and high birth rate, and consanguineous marriage favoured in many communities, there is a high prevalence of genetic disorders in India. An estimated 495,000 infants with congenital malformations, 390,000 with G6PD deficiency, 21,400 with Down syndrome, 9,000 with beta-thalassaemia, 5,200 with sickle cell disease, and 9,760 with amino acid disorders are born each year. The prevalence of late-onset multi-factorial disorders (including coronary artery disease, hypertension and psychiatric disorders) is also large. Due to inadequate diagnostic, management and rehabilitation facilities, the burden of these disorders is greater than in Western countries. Although genetic diseases receive little attention from the health services, research funding by the government has been liberal. Community control of common disorders like thalassaemia, Down syndrome, neural tube defects, and muscular dystrophies deserves high priority, and genetic services should be integrated into the existing primary health care and medical services. Most genetic counselling would have to be provided through training physicians who staff the district and medical school hospitals. To ensure future progress, there is a need to establish additional departments of medical genetics in medical schools.

Entities:  

Year:  2002        PMID: 14960891     DOI: 10.1159/000066335

Source DB:  PubMed          Journal:  Community Genet        ISSN: 1422-2795


  25 in total

1.  Status of Newborn Screening and Inborn Errors of Metabolism in India.

Authors:  Seema Kapoor; B K Thelma
Journal:  Indian J Pediatr       Date:  2018-05-07       Impact factor: 1.967

Review 2.  Genetics and public health--evolution, or revolution?

Authors:  Jane L Halliday; Veronica R Collins; Mary Anne Aitken; Martin P M Richards; Craig A Olsson
Journal:  J Epidemiol Community Health       Date:  2004-11       Impact factor: 3.710

Review 3.  Neonatology in developed and developing nations.

Authors:  Pankaj Garg; Srinivas Bolisetty
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 1.967

4.  B/L Basal Ganglia Lesions in a Child Leading to a Diagnosis of Glucose-6-Phosphate Dehydrogenase Deficiency.

Authors:  Nidhi Prabhakar; Chirag K Ahuja; Niranjan Khandelwal
Journal:  Ann Neurosci       Date:  2017-11-21

5.  Newborn screening for G6PD deficiency--why is it important for India?

Authors:  R Kishore Kumar; Nandini Nagar; Enzo Ranieri
Journal:  Indian J Pediatr       Date:  2013-04-19       Impact factor: 1.967

6.  Newborn Screening for Congenital Adrenal Hyperplasia in India: What Do We Need to Watch Out for?

Authors:  R Kishore Kumar; Hari Das; Prakash Kini
Journal:  J Obstet Gynaecol India       Date:  2015-06-11

7.  Neonatal screening for glucose-6-phosphate dehydrogenase deficiency.

Authors:  Mritunjay Pao; Anjali Kulkarni; Vidya Gupta; Sushma Kaul; Saroja Balan
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

8.  Thalassemia major and intermedia in jammu and kashmir, India: a regional transfusion centre experience.

Authors:  Rahul Vasudev; Vijay Sawhney
Journal:  Indian J Hematol Blood Transfus       Date:  2013-10-22       Impact factor: 0.900

9.  Evaluation of the levels of folate, vitamin B12, homocysteine and fluoride in the parents and the affected neonates with neural tube defect and their matched controls.

Authors:  Simmi K Ratan; Kamal Nain Rattan; Ravindra Mohan Pandey; Savita Singhal; Simmi Kharab; Manju Bala; Veena Singh; Atul Jhanwar
Journal:  Pediatr Surg Int       Date:  2008-05-08       Impact factor: 1.827

10.  Genetic counseling and prenatal diagnosis in India--experience at Sir Ganga Ram Hospital.

Authors:  I C Verma; Renu Saxena; Meena Lall; Sunita Bijarnia; Rajesh Sharma
Journal:  Indian J Pediatr       Date:  2003-04       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.